GSK656: Clinical Trials

3 trials of GSK656, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Recruiting 1

Follow GSK656: new trials by email Literature Review of GSK656 trials Research Report on GSK656

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Repeat-dose Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With Ganfeborole in Female Participants of Non-childbearing Potential
Ganfeborole, Microgynon - Tuberculosis
Phase 1RecruitingGlaxoSmithKline282026-08-202026-10-02
A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age
Microgynon, GSK3036656 - Tuberculosis
Phase 1CompletedGlaxoSmithKline202024-04-052025-08-26
First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects
GSK3036656, Placebo - Tuberculosis
Phase 1CompletedGlaxoSmithKline302017-04-022019-04-19

Conditions studied

Tuberculosis (3)

Sponsors

GlaxoSmithKline (3)

Countries

Spain (2)  ·  United Kingdom (1)

Results publications

PMID 31182528

NIH funding

2015 (1)